Pesch, B.* ; Gawrych, K.* ; Rabstein, S.* ; Weiss, T.* ; Casjens, S.* ; Rihs, H.P.* ; Ding, H.* ; Angerer, J.* ; Illig, T. ; Klopp, N. ; Bueno-de-Mesquita, H.B.* ; Ros, M.M.* ; Kaaks, R.* ; Chang-Claude, J.* ; Roswall, N.* ; Tjønneland, A.* ; Overvad, K.* ; Clavel-Chapelon, F.* ; Boutron-Ruault, M.C.* ; Dossus, L.* ; Boeing, H.* ; Weikert, S.* ; Trichopoulos, D.* ; Palli, D.* ; Sieri, S.* ; Tumino, R.* ; Panico, S.* ; Quirós, J.R.* ; Gonzalez, C.* ; Sánchez, M.J.* ; Dorronsoro, M.* ; Navarro, C.* ; Barricarte, A.* ; Ljungberg, B.* ; Johansson, M.* ; Ulmert, D.* ; Ehrnström, R.* ; Khaw, K.T.* ; Wareham, N.J.* ; Key, T.J.* ; Ferrari, P.* ; Romieu, I.* ; Riboli, E.* ; Brüning, T* ; Vineis, P.*
N-acetyltransferase 2 phenotype, occupation, and bladder cancer risk: Results from the EPIC cohort.
Cancer Epidemiol. Biomarkers Prev. 22, 2055-2065 (2013)
BACKGROUND: An association between N-acetyltransferase 2 (NAT2) slow acetylation and bladder cancer has been consistently observed in epidemiologic studies. However, evidence has been mainly derived from case-control studies and was sparse from cohort studies. We evaluated the association between NAT2 slow acetylation and bladder cancer in a case-control study nested in the European Prospective Investigation into Cancer and Nutrition. METHODS: Exposure to aromatic amines and polycyclic aromatic hydrocarbons (PAH) could be assessed for 754 cases and 833 controls for whom occupational information was documented. A semiquantitative job-exposure matrix was applied to at-risk occupations to estimate the exposure as low, medium, or high based on tertiles of the distribution of the exposure score in controls. Using a comprehensive genotyping, NAT2 acetylation status could be categorized from 6-single-nucleotide polymorphism genotypes as slow or fast in 607 cases and 695 controls with DNA from archived blood samples. RESULTS: Occupational exposure to aromatic amines and PAH was associated with an increased bladder cancer risk [upper tertile of the distribution of the exposure score: OR = 1.37; 95% confidence interval (CI), 1.02-1.84, and OR = 1.50; 95% CI, 1.09-2.05, respectively]. NAT2 slow acetylation did not modify these risk estimates and was not itself associated with bladder cancer risk (OR = 1.02; 95% CI, 0.81-1.29). CONCLUSIONS: These findings confirm established or suspected occupational risk factors but not the anticipated role of NAT2 slow acetylation in bladder cancer. No interaction was detected between NAT2 and any exposure of interest, including smoking. IMPACT: Genetic testing for NAT2 would be inappropriate in occupational settings.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Nat2 Slow Acetylation ; Polycyclic Aromatic-hydrocarbons ; Gene-environment Interaction ; Urinary-bladder ; Tobacco-smoke ; Gstm1 Null ; Population ; Genotype ; N-acetyltransferase-2 ; Metaanalysis
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2013
Prepublished im Jahr
HGF-Berichtsjahr
2013
ISSN (print) / ISBN
1055-9965
e-ISSN
1538-7755
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 22,
Heft: 11,
Seiten: 2055-2065
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
American Association for Cancer Research (AACR)
Verlagsort
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30501 - Systemic Analysis of Genetic and Environmental Factors that Impact Health
Forschungsfeld(er)
Genetics and Epidemiology
PSP-Element(e)
G-504200-001
Förderungen
Copyright
Erfassungsdatum
2013-11-25